These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
71 related items for PubMed ID: 20646020
1. Cervical cancer: cytological cervical screening in Iceland and implications of HPV vaccines. Sigurdsson K. Cytopathology; 2010 Aug; 21(4):213-22. PubMed ID: 20646020 [Abstract] [Full Text] [Related]
2. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Jenkins D. Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221 [Abstract] [Full Text] [Related]
3. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Adams M, Jasani B, Fiander A. Vaccine; 2007 Apr 20; 25(16):3007-13. PubMed ID: 17292517 [Abstract] [Full Text] [Related]
4. Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies. Canfell K, Shi JF, Lew JB, Walker R, Zhao FH, Simonella L, Chen JF, Legood R, Smith MA, Nickson C, Qiao YL. Vaccine; 2011 Mar 16; 29(13):2487-94. PubMed ID: 21211586 [Abstract] [Full Text] [Related]
5. Cervical screening in the era of HPV vaccination. Farnsworth A. Cytopathology; 2010 Aug 16; 21(4):211-2. PubMed ID: 20646019 [No Abstract] [Full Text] [Related]
9. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Wright TC, Bosch FX, Franco EL, Cuzick J, Schiller JT, Garnett GP, Meheus A. Vaccine; 2006 Aug 31; 24 Suppl 3():S3/251-61. PubMed ID: 16950014 [Abstract] [Full Text] [Related]
10. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP. PLoS Med; 2006 May 31; 3(5):e138. PubMed ID: 16573364 [Abstract] [Full Text] [Related]
11. [Can human papillomavirus testing and vaccination prevent cervical cancer?]. Lie AK, Bjørge T, Helland A, Hagen B, Skjeldestad FE, Hagmar B, Thoresen S. Tidsskr Nor Laegeforen; 2001 Oct 20; 121(25):2947-51. PubMed ID: 11715778 [Abstract] [Full Text] [Related]
12. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan. Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH. Vaccine; 2008 Aug 19; 26 Suppl 12():M60-70. PubMed ID: 18945415 [Abstract] [Full Text] [Related]
14. Integrating human papillomavirus vaccination in cervical cancer control programmes. Franco EL, Coutlée F, Ferenczy A. Public Health Genomics; 2009 Aug 19; 12(5-6):352-61. PubMed ID: 19684447 [Abstract] [Full Text] [Related]
18. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium. Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C. Cancer Epidemiol Biomarkers Prev; 2009 Jan 19; 18(1):321-30. PubMed ID: 19124515 [Abstract] [Full Text] [Related]